Evidence map›Paper›PMID 35912744›Full record

ArticleJournal of Alzheimer's disease : JAD2022

Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.

Silvia Cascini, Nera Agabiti, Claudia Marino, Anna Acampora, Maria Balducci, Enrico Calandrini, Marina Davoli, Anna Maria Bargagli

Open access · hybridAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Observational
  3. A National Survey of Day Care Centers Hosting People With Dementia in Italy.International journal of geriatric psychiatry · 2025
    Article
  4. Review
  5. Article
  6. A new national survey of centers for cognitive disorders and dementias in Italy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  7. Article
  8. Observational
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Silvia CasciniDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Nera AgabitiDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Claudia MarinoDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Anna AcamporaDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Maria BalducciDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Enrico CalandriniDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Marina DavoliDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.
Anna Maria BargagliDepartment of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe identification of risk factors for SARS-CoV-2 infection and mortality in patients with dementia is a key aspect to support clinical decisions and public health interventions.

objectiveTo assess the incidence of SARS-CoV-2 infection and COVID-19 related death in a cohort of patients with dementia residing in the Lazio region and to investigate predicting factors for both infection and mortality.

methodsThis population-based study used information from administrative databases and the SARS-CoV-2 infection surveillance system. Patients with dementia (age ≥65) were enrolled as of December 31, 2019 and followed-up until February 28, 2021. Cumulative risk of infection and death within 60 days of infection onset, and age-standardized incidence (SIR) and mortality (SMR) ratios were calculated. Logistic regression models were applied to identify factors associated with infection and mortality.

resultsAmong 37,729 dementia patients, 2,548 had a diagnosis of SARS-CoV-2 infection. The crude risk of infection was 6.7%. An increase in risk of infection was observed both in women (SIR 1.72; 95% CI 1.64-1.80) and men (SIR 1.43; 95% CI 1.33-1.54). Pneumonia, cerebrovascular and blood diseases, femur fracture, anxiety, antipsychotic and antithrombotic use were associated with an increased risk of infection. The crude risk of death was 31.0%, the SMRs 2.32 (95% CI 2.05-2.65) for men, and 2.82 (95% CI 2.55-3.11) for women. Factors associated with mortality included: male gender, age ≥85, symptoms at the diagnosis, antipsychotic and systemic antibiotics treatment.

conclusionThese findings emphasize the need of close and tailored monitoring of dementia patients to reduce the impact of COVID-19 on this fragile population.

Indexed as

Antipsychotic AgentsCOVID-19DementiaAgedAnti-Bacterial AgentsCohort StudiesFemaleFibrinolytic AgentsHumansIncidenceMaleSARS-CoV-2Anti-Bacterial AgentsAntipsychotic AgentsFibrinolytic AgentsAdministrative databasesAlzheimer’s diseasecohort studyCOVID-19dementiaprognostic factorsSARS-CoV-2 infection

Identifiers

PMID35912744
PMCPMC9535569
OpenAlexW4288713247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.